MDRX logo

Veradigm (MDRX) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$188.35 M
-$342.75 M-64.54%

December 31, 2021

Summary

Performance

1-Year Change

-64.54%

3-Year Change

+8.1%

5-Year Change

+57.66%

15-Year Change

+57.66%

MDRX Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.7%
MDRX annual cash & cash equivalents is higher than 81.7% of companies in Healthcare sector

High & Low

All-time High

$531.10 M
MDRX annual cash & cash equivalents is currently -64.54% below its historical high of $531.10 million

3-Year Low

$188.35 M
MDRX annual cash & cash equivalents is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
MDRX previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
MDRX next annual earnings announcement has not yet been scheduled

OtherMDRXbalance sheetmetrics:

Quarterly Total Assets

$1.69 B
MDRX quarterly total assets is $1.69 billion

Quarterly Current Assets

$810.77 M
MDRX quarterly total current assets is $810.77 million

Quarterly Total Liabilities

$513.64 M
MDRX quarterly total liabilities is $513.64 million

Quarterly Current Liabilities

$253.09 M
MDRX quarterly total current liabilities is $253.09 million

Quarterly Cash And Cash Equivalents

$492.60 M
-$7.56 M-1.51%

September 30, 2022

Summary

Performance

3-Month Change

-1.51%

1-Year Change

+129.99%

3-Year Change

+141.11%

5-Year Change

+141.11%

MDRX Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.37%
MDRX quarterly cash and cash equivalents is higher than 91.37% of companies in Healthcare sector

High & Low

All-time High

$531.10 M
MDRX quarterly cash and cash equivalents is currently -7.25% below its historical high of $531.10 million

3-Year Low

$82.78 M
MDRX quarterly cash and cash equivalents is currently +495.06% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
MDRX previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
MDRX next earnings announcement has not yet been scheduled

OtherMDRXbalance sheetmetrics:

Quarterly Total Assets

$1.69 B
MDRX quarterly total assets is $1.69 billion

Quarterly Current Assets

$810.77 M
MDRX quarterly total current assets is $810.77 million

Quarterly Total Liabilities

$513.64 M
MDRX quarterly total liabilities is $513.64 million

Quarterly Current Liabilities

$253.09 M
MDRX quarterly total current liabilities is $253.09 million

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

MDRX Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-64.5%+130.0%
3 y3 years+8.1%+141.1%
5 y5 years+57.7%+141.1%

MDRX Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-1.5%+495.1%
5 y5-year-64.5%+45.3%-7.3%+495.1%
alltimeall time-64.5%>+9999.0%-7.3%+9953.1%

Veradigm Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2022
-
$492.60 M(-1.5%)
Jun 2022
-
$500.16 M(+504.2%)
Mar 2022
-
$82.78 M(-56.0%)
Dec 2021
$188.35 M(-64.5%)
$188.35 M(-12.1%)
Sep 2021
-
$214.18 M(-6.6%)
Jun 2021
-
$229.25 M(-55.3%)
Mar 2021
-
$513.40 M(-3.3%)
Dec 2020
$531.10 M(+309.6%)
$531.10 M(+142.8%)
Sep 2020
-
$218.70 M(+9.9%)
Jun 2020
-
$199.00 M(-2.6%)
Mar 2020
-
$204.31 M(+57.6%)
Dec 2019
$129.67 M(-25.6%)
$129.67 M(+0.2%)
Sep 2019
-
$129.35 M(-6.9%)
Jun 2019
-
$138.90 M(+1.3%)
Mar 2019
-
$137.17 M(-21.3%)
Dec 2018
$174.24 M(+45.8%)
$174.24 M(+55.9%)
Sep 2018
-
$111.78 M(-17.7%)
Jun 2018
-
$135.85 M(+0.6%)
Mar 2018
-
$135.00 M(+13.0%)
Dec 2017
$119.47 M(+25.0%)
$119.47 M(+14.5%)
Sep 2017
-
$104.30 M(+26.1%)
Jun 2017
-
$82.71 M(-20.8%)
Mar 2017
-
$104.39 M(+9.2%)
Dec 2016
$95.61 M(-18.2%)
$95.61 M(+23.8%)
Sep 2016
-
$77.25 M(-14.8%)
Jun 2016
-
$90.66 M(-9.5%)
Mar 2016
-
$100.12 M(-14.3%)
Dec 2015
$116.87 M(+119.8%)
$116.87 M(+27.9%)
Sep 2015
-
$91.40 M(+19.4%)
Jun 2015
-
$76.54 M(-13.5%)
Mar 2015
-
$88.48 M(+66.4%)
Dec 2014
$53.17 M(-15.5%)
$53.17 M(+42.4%)
Sep 2014
-
$37.34 M(-4.9%)
Jun 2014
-
$39.25 M(-5.6%)
Mar 2014
-
$41.58 M(-34.0%)
Dec 2013
$62.95 M(-39.4%)
$62.95 M(+3.6%)
Sep 2013
-
$60.79 M(-15.6%)
Jun 2013
-
$71.98 M(-21.9%)
Mar 2013
-
$92.23 M(-11.3%)
Dec 2012
$103.96 M(-34.1%)
$103.96 M(+11.0%)
Sep 2012
-
$93.67 M(-22.2%)
Jun 2012
-
$120.37 M(-31.5%)
Mar 2012
-
$175.68 M(+11.4%)
Dec 2011
$157.75 M(+21.9%)
$157.75 M(+86.1%)
Sep 2011
-
$84.78 M(-26.7%)
Jun 2011
-
$115.67 M(-20.5%)
Mar 2011
-
$145.45 M(+21.1%)
Dec 2010
$129.40 M
-
DateAnnualQuarterly
Sep 2010
-
$120.07 M(-16.3%)
May 2010
-
$143.41 M(+23.9%)
May 2010
$143.41 M(+101.5%)
-
Feb 2010
-
$115.76 M(+30.6%)
Nov 2009
-
$88.65 M(+4.5%)
Aug 2009
-
$84.85 M(+19.2%)
May 2009
$71.16 M(+62.5%)
$71.16 M(+1.9%)
Feb 2009
-
$69.86 M(+1.4%)
Nov 2008
-
$68.89 M(-3.2%)
Sep 2008
-
$71.19 M(+40.0%)
Jun 2008
-
$50.84 M(+16.3%)
Mar 2008
-
$43.72 M(-0.1%)
Dec 2007
$43.78 M(+3.1%)
$43.78 M(+37.0%)
Sep 2007
-
$31.97 M(-20.8%)
Jun 2007
-
$40.38 M(-8.7%)
Mar 2007
-
$44.22 M(+4.1%)
Dec 2006
$42.46 M(-30.3%)
$42.46 M(+18.8%)
Sep 2006
-
$35.73 M(+8.4%)
Jun 2006
-
$32.98 M(-6.4%)
Mar 2006
-
$35.23 M(-42.2%)
Dec 2005
$60.91 M(+258.9%)
$60.91 M(+61.5%)
Sep 2005
-
$37.72 M(+2.6%)
Jun 2005
-
$36.78 M(+45.6%)
Mar 2005
-
$25.26 M(+48.8%)
Dec 2004
$16.97 M(+27.3%)
$16.97 M(-64.1%)
Sep 2004
-
$47.33 M(+158.1%)
Jun 2004
-
$18.34 M(+52.8%)
Mar 2004
-
$12.00 M(-10.0%)
Dec 2003
$13.34 M(-22.7%)
$13.34 M(+27.1%)
Sep 2003
-
$10.50 M(-41.6%)
Jun 2003
-
$17.97 M(-1.4%)
Mar 2003
-
$18.23 M(+5.7%)
Dec 2002
$17.25 M(-49.5%)
$17.25 M(-6.6%)
Sep 2002
-
$18.47 M(-12.6%)
Jun 2002
-
$21.14 M(-4.4%)
Mar 2002
-
$22.12 M(-35.2%)
Dec 2001
$34.12 M(-55.4%)
$34.12 M(-15.9%)
Sep 2001
-
$40.58 M(-11.6%)
Jun 2001
-
$45.92 M(-8.1%)
Mar 2001
-
$49.96 M(-34.7%)
Dec 2000
$76.51 M(+88.5%)
$76.51 M(-1.5%)
Sep 2000
-
$77.66 M(-6.7%)
Jun 2000
-
$83.24 M(-24.7%)
Mar 2000
-
$110.48 M(+172.1%)
Dec 1999
$40.60 M(+5700.0%)
$40.60 M(+49.8%)
Sep 1999
-
$27.10 M(+453.1%)
Jun 1999
-
$4.90 M(-38.8%)
Mar 1999
-
$8.00 M
Dec 1998
$700.00 K
-

FAQ

  • What is Veradigm annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Veradigm?
  • What is Veradigm annual cash & cash equivalents year-on-year change?
  • What is Veradigm quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Veradigm?
  • What is Veradigm quarterly cash and cash equivalents year-on-year change?

What is Veradigm annual cash & cash equivalents?

The current annual cash & cash equivalents of MDRX is $188.35 M

What is the all time high annual cash & cash equivalents for Veradigm?

Veradigm all-time high annual cash & cash equivalents is $531.10 M

What is Veradigm annual cash & cash equivalents year-on-year change?

Over the past year, MDRX annual cash & cash equivalents has changed by -$342.75 M (-64.54%)

What is Veradigm quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of MDRX is $492.60 M

What is the all time high quarterly cash and cash equivalents for Veradigm?

Veradigm all-time high quarterly cash and cash equivalents is $531.10 M

What is Veradigm quarterly cash and cash equivalents year-on-year change?

Over the past year, MDRX quarterly cash and cash equivalents has changed by +$278.42 M (+129.99%)